Biofficient Successfully Launches "Match.com" for Biotech Industry at DIA 2013
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers
Biofficient Inc. today announced the successful launch of its new platform to accelerate the outsourcing process for the biopharmaceutical drug development process. The company debuted the product to the biotech industry at last week’s annual DIA conference in Boston, MA.
Biofficient.com, the company’s website which hosts the platform, offers a streamlined solution to the arduous process of matching clinical trial sponsors’ specific needs with a comprehensive database of contract services provided by a global list of industry vendors. Completely secure and confidential, sponsors are able to create and send their RFPs to the vendors they select from a list generated by Biofficient’s adaptive matching algorithms.
On the other side of the process, Biofficient opens doors to new business for thousands of vendors that may otherwise not have been aware of valuable projects within their realm of expertise. By building out their free vendor profile on Biofficient’s easy-to-navigate site, qualified companies become a visible, viable contender for business in a highly competitive marketplace.
“We saw an opportunity to greatly improve the inefficiencies on both sides of the biopharmaceutical RFP process, and built out a solution that is beneficial to both the trial sponsors and contract service vendors. In a market that is increasingly relying on outsourced work, a faster, simpler, more cost-efficient way of bringing both parties together and improving the quality of the entire experience as a whole is critical,” said Biofficient CEO Bret Siarkowski..
For more information about Biofficient, or to register for their platform, visit www.biofficient.com or call (888) 560-7007.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
